[
  {
    "ts": null,
    "headline": "Taking Stock of Thermo Fisher Scientific (TMO) Valuation After Analyst Upgrades and Bioprocessing, Cardio Testing Moves",
    "summary": "Thermo Fisher Scientific (TMO) just picked up fresh buy ratings on the back of its Asian bioprocessing expansion and a new cardiovascular risk testing partnership, and investors are treating that combination as a meaningful confidence signal. See our latest analysis for Thermo Fisher Scientific. Although Thermo Fisher’s share price is slightly softer in the very short term, a roughly 21 percent 90 day share price return suggests momentum is rebuilding as investors reprice its Asia buildout...",
    "url": "https://finnhub.io/api/news?id=67ecceaedfac7de2367e6f411dd3ff045612a837de0cccd45cfb0cab0bc01bd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765696147,
      "headline": "Taking Stock of Thermo Fisher Scientific (TMO) Valuation After Analyst Upgrades and Bioprocessing, Cardio Testing Moves",
      "id": 137792399,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific (TMO) just picked up fresh buy ratings on the back of its Asian bioprocessing expansion and a new cardiovascular risk testing partnership, and investors are treating that combination as a meaningful confidence signal. See our latest analysis for Thermo Fisher Scientific. Although Thermo Fisher’s share price is slightly softer in the very short term, a roughly 21 percent 90 day share price return suggests momentum is rebuilding as investors reprice its Asia buildout...",
      "url": "https://finnhub.io/api/news?id=67ecceaedfac7de2367e6f411dd3ff045612a837de0cccd45cfb0cab0bc01bd0"
    }
  }
]